Histopathological analyses have demonstrated that the expression of CDX2 is low in invasive colorectal cancer cells, which localize at the tumor/stroma interface, but is restored in metastases, at a level corresponding to that of the primary tumor (21). Here, CDX2 is linked to neoplasm.